Evidence map›Paper›PMID 35708845›Full record

Trial reportHeart and vessels2022

Kidney function deterioration is dependent on blood pressure levels: 11.2 year follow-up in diabetic patients.

Hirofumi Soejima, Hisao Ogawa, Takeshi Morimoto, Sadanori Okada, Chisa Matsumoto, Masafumi Nakayama, Izuru Masuda, Hideaki Jinnouchi, Masako Waki, Yoshihiko Saito and 1 more

Abstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Heart and vessels, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Hirofumi SoejimaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan. yuuki@gpo.kumamoto-u.ac.jp.
Hisao OgawaKumamoto University, Kumamoto, Japan.
Takeshi MorimotoDepartment of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan.
Sadanori OkadaDepartment of Diabetes and Endocrinology, Nara Medical University, Kashihara, Japan.
Chisa MatsumotoDepartment of Cardiology, Center for Health Surveillance and Preventive Medicine, Tokyo Medical University Hospital, Tokyo, Japan.
Masafumi NakayamaNakayama Cardiovascular Clinic, Amakusa, Japan.
Izuru MasudaTakeda Hospital Medical Examination Center, Kyoto, Japan.
Hideaki JinnouchiDepartment of Internal Medicine, Jinnouchi Hospital Diabetes Care Center, Kumamoto, Japan.
Masako WakiFood Safety Commission of Japan, Tokyo, Japan.
Yoshihiko SaitoDepartment of Cardiovascular Medicine, Nara Medical University, Kashihara, Japan.
JPAD Trial Investigators
Nara Medical University · JPKumamoto University · JPHyogo Medical University · JPKumamoto Health Science University · JPTakeda (Japan) · JPMinamiaoyama Eye Clinic · JPTokyo Medical University Hospital · JP

Funding

Japan Society for the Promotion of Science 18K08521Ministry of Health, Labour and Welfare H16-Junkanki-004Ministry of Health, Labour and Welfare H27-Junkanki-Ippan-001
6 · The paper itself

Abstract

There is little evidence of how blood pressure level over 10 years affects the decline of estimated glomerular filtration rate (eGFR) in diabetic patients. The Japanese primary prevention of atherosclerosis with aspirin for diabetes (JPAD) trial was a multicenter, randomized, clinical trial done from 2002 to 2008. After completion of the JPAD trial, we followed up the patients until 2019 as a cohort study. We defined late-stage kidney disease (LSKD) as eGFR < 30 ml/min/1.73 m

Indexed as

Diabetes MellitusHydroxymethylglutaryl-CoA Reductase InhibitorsHypertensionKidney DiseasesAgedAspirinBlood PressureCohort StudiesFollow-Up StudiesGlomerular Filtration RateGlycated HemoglobinHumansKidneyMaleRisk FactorsAspirinGlycated HemoglobinHydroxymethylglutaryl-CoA Reductase InhibitorsEstimated glomerular filtration rateHemodialysisLate-stage kidney diseaseSystolic blood pressure

Identifiers

PMID35708845
OpenAlexW4283020218

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.